PROF News

Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow

Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease

PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health

Profound Medical Announces Upcoming Investor Events

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Profound Surpasses 2025 TULSA-PRO® Installed Base Goal

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

Profound Medical Corp. Announces Closing of Private Placement

Profound Medical Corp. Announces Upsize of Private Placement

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th